Cited by 168Biochemical and Molecular ResearchCancer, Hypoxia, and MetabolismFolate and B Vitamins Research

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy

Open access
Shuvalov, Oleg, Petukhov, Alexey, Daks, Alexandra, Fedorova, Olga, Vasileva, Elena, Barlev, Nickolai A.·2017·Oncotarget

Abstract

// Oleg Shuvalov 1 , Alexey Petukhov 1, 2 , Alexandra Daks 1 , Olga Fedorova 1 , Elena Vasileva 1 , Nickolai A. Barlev 1 1 Institute of Cytology RAS, Saint-Petersburg, Russian Federation 2 Institute of Hematology, Almazov Federal North-West Medical Research Centre, Saint-Petersburg, Russian Federation Correspondence to: Oleg Shuvalov, email: oleg8988@mail.ru Nickolai A. Barlev, email: nick.a.barlev@gmail.com Keywords: cancer metabolism, one-carbon metabolism, anti-cancer therapy, c-Myc, p53 Received: October 19, 2016 Accepted: December 02, 2016 Published: February 03, 2017 ABSTRACT Cancer-related metabolism has recently emerged as one of the “hallmarks of cancer”. It has several important features, including altered metabolism of glucose and glutamine. Importantly, altered cancer metabolism connects different biochemical pathways into the one fine-tuned metabolic network, which stimulates high proliferation rates and plasticity to malignant cells. Among the keystones of cancer metabolism are one-carbon metabolism and nucleotide biosynthesis, which provide building blocks to anabolic reactions. Accordingly, the importance of these metabolic pathways for anticancer therapy has well been documented by more than fifty years of clinical use of specific metabolic inhibitors – methotrexate and nucleotides analogs. In this review we discuss one-carbon metabolism and nucleotide biosynthesis as common and specific features of many, if not all, tumors. The key enzymes involved in these pathways also represent promising anti-cancer therapeutic targets. We review different aspects of these metabolic pathways including their biochemistry, compartmentalization and expression of the key enzymes and their regulation at different levels. We also discuss the effects of known inhibitors of these pathways as well as the recent data on other enzymes of the same pathways as perspective pharmacological targets.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.15053

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metabolic reprogramming is a known hallmark of cancer cells, in which they manifest diverse metabolic phenotypes to maintain their proliferation and to combat anticancer therapies.

    “Metabolic reprogramming is a known hallmark of cancer cells, in which they manifest diverse metabolic phenotypes to maintain their proliferation and to combat anticancer therapies (Shuvalov et al., 2017; Sun et al., 2020).”
  • One-carbon metabolism supplies cancer cells with nucleotides, SAM, glutathione, some amino acids, etc.

    “One-carbon metabolism supplies cancer cells with nucleotides, which limit cell divisions: SAM—the main donor of methyl groups; glutathione—an important factor of redox homeostasis; some amino acids; etc. [40,65].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A.
Affiliations
  • Institute of Cytology (RU)
  • Federal Almazov North-West Medical Research Centre (RU)
Corresponding author
Barlev, Nickolai A.
Venue
Oncotarget
Published
2017-02-03
Volume
8
Issue
14
Pages
23955-23977
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2585195223
Cited by
168
References
177
Citations by year
2026: 18 · 2025: 22 · 2024: 20 · 2023: 14 · 2022: 22 · 2021: 24 · 2020: 22 · 2019: 13 · 2018: 11 · 2017: 2
FWCI
1.23
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Oncotarget (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Russian Foundation for Basic Research (14-50-00068, 16-34-60228)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Rheumatology › Folate and B Vitamins Research
Keywords
one-carbon metabolism, nucleotide synthesis, cancer metabolism, anticancer drug targets, methotrexate, nucleotide analogues, c-Myc, p53, metabolic inhibitors, metabolic enzymes
MeSH terms
Animals, Carbon, Humans, Neoplasms, Nucleotides, Metabolic Networks and Pathways, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review